Clinical Guidelines

ADA and EASD Publish Guidance on Diagnosis, Management of Type 1 Diabetes

October 01, 2021

Published on September 30, the consensus report provides perspective on diagnosis and management of type 1 diabetes, including a diagnosis algorithm and insight on CGM specific to type 1 diabetes, which the writing group noted is lacking from previous guidance.

AHA Outlines Weight Loss Strategies for Preventing Obesity Hypertension

September 20, 2021

Released on September 20, the latest scientific statement from the AHA outlines potential strategies, including lifestyle modifications, pharmacologic therapies, and weight loss surgery, for the prevention and treatment of obesity hypertension.

Greater Adherence to Diabetes Guidelines Needed in US Medical Practices

September 17, 2021

Jennifer Green, MD, explains how delays in the adoption of new guideline recommendations are holding back optimal management of type 2 diabetes in the US.

North American Menopause Society Releases Updated Osteoporosis Guidance

September 07, 2021

The organization's first update since their 2010 position statement, the osteoporosis position statement reflects more than a decade of advances in knowledge related to diagnosis and management of osteoporosis.

USPSTF Lowers Recommended Screening Age for Type 2 Diabetes

August 24, 2021

The US Preventive Services Task Force has issued a B-graded recommendation statement lowering their recommended age for screening for type 2 diabetes from 40 to 35 years.

USPSTF Reaffirms 2014 Guidance on Screening for Gestational Diabetes

August 10, 2021

The latest recommendation statement reaffirms the USPSTF's 2014 guidance, which included a B recommendation for screening for gestational diabetes at 24 weeks of gestation or after.

USPSTF Issues Recommendation on Interventions for Healthy Weight Gain During Pregnancy

May 25, 2021

The USPSTF has issued the organization's first recommendation on interventions for promoting healthy weight gain during pregnancy and also provided an overview of the evidence base used for the recommendation statement.

Physician Perspective: AHA Guidelines on Managing CVD Risk During Menopause

December 20, 2020

Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.

CV Benefit of Dulaglutide Present Regardless of Background Metformin Use

September 05, 2020

An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use.

Medtronic's MiniMed 770G Receives FDA Approval in Children 2 to 6 Years Old

August 31, 2020

The MiniMed 770G becomes the first system to receive approval for children in this age group.